| Clarence Herbert Clifton Iii, DPT | |
|
4957 Swinyar Dr Ste 103, Ooltewah, TN 37363-2205 | |
| (423) 664-0800 | |
| (423) 664-0801 |
| Full Name | Clarence Herbert Clifton Iii |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 17 Years |
| Location | 4957 Swinyar Dr Ste 103, Ooltewah, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144528092 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 7856 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chattanooga Orthopaedic Group Pc | 1254229156 | 67 |
News Archive
Patients and physicians "need to know not just whether a new drug outperforms a placebo, but whether it's a real advance on what's already on the market," Richard Friedman, a professor of psychiatry at Weill Cornell Medical College, writes in a New York Times opinion piece.
ScinoPharm and Foresee Pharmaceuticals, Inc. jointly announced today that an investment agreement to form a joint venture has been signed. This venture looks to develop a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug product, where Leuprolide will be formulated in a proprietary controlled-release drug delivery system originally developed by Foresee and transferred to the joint venture.
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Arjen Dondorp, deputy director of the Mahidol Oxford Tropical Research Unit at Mahidol University in Bangkok, Thailand, and colleagues discuss the need to combat antimalarial drug resistance in this New England Journal of Medicine opinion piece, writing, "Researchers, funders, and policy leaders must recognize the urgency of the problem, take action to address simultaneously several important knowledge gaps, and focus immediately on eliminating the threat of artemisinin resistance."
Devex examines the April 20 announcement by the Global Health Council (GHC) that it will cease operations in the year of its 40th anniversary, discussing possible reasons why the organization is closing and what lies ahead for its members. According to Devex, a lack of funding, operating challenges, and "a lack of focus" all potentially contributed to the organization's impending closure.
› Verified 1 days ago
| Provider Name | Chattanooga Orthopaedic Group Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548203821 PECOS PAC ID: 1254229156 Enrollment ID: O20040310000657 |
News Archive
Patients and physicians "need to know not just whether a new drug outperforms a placebo, but whether it's a real advance on what's already on the market," Richard Friedman, a professor of psychiatry at Weill Cornell Medical College, writes in a New York Times opinion piece.
ScinoPharm and Foresee Pharmaceuticals, Inc. jointly announced today that an investment agreement to form a joint venture has been signed. This venture looks to develop a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug product, where Leuprolide will be formulated in a proprietary controlled-release drug delivery system originally developed by Foresee and transferred to the joint venture.
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Arjen Dondorp, deputy director of the Mahidol Oxford Tropical Research Unit at Mahidol University in Bangkok, Thailand, and colleagues discuss the need to combat antimalarial drug resistance in this New England Journal of Medicine opinion piece, writing, "Researchers, funders, and policy leaders must recognize the urgency of the problem, take action to address simultaneously several important knowledge gaps, and focus immediately on eliminating the threat of artemisinin resistance."
Devex examines the April 20 announcement by the Global Health Council (GHC) that it will cease operations in the year of its 40th anniversary, discussing possible reasons why the organization is closing and what lies ahead for its members. According to Devex, a lack of funding, operating challenges, and "a lack of focus" all potentially contributed to the organization's impending closure.
› Verified 1 days ago
| Provider Name | Agilitas Usa Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1962417444 PECOS PAC ID: 3375454648 Enrollment ID: O20041115000337 |
News Archive
Patients and physicians "need to know not just whether a new drug outperforms a placebo, but whether it's a real advance on what's already on the market," Richard Friedman, a professor of psychiatry at Weill Cornell Medical College, writes in a New York Times opinion piece.
ScinoPharm and Foresee Pharmaceuticals, Inc. jointly announced today that an investment agreement to form a joint venture has been signed. This venture looks to develop a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug product, where Leuprolide will be formulated in a proprietary controlled-release drug delivery system originally developed by Foresee and transferred to the joint venture.
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Arjen Dondorp, deputy director of the Mahidol Oxford Tropical Research Unit at Mahidol University in Bangkok, Thailand, and colleagues discuss the need to combat antimalarial drug resistance in this New England Journal of Medicine opinion piece, writing, "Researchers, funders, and policy leaders must recognize the urgency of the problem, take action to address simultaneously several important knowledge gaps, and focus immediately on eliminating the threat of artemisinin resistance."
Devex examines the April 20 announcement by the Global Health Council (GHC) that it will cease operations in the year of its 40th anniversary, discussing possible reasons why the organization is closing and what lies ahead for its members. According to Devex, a lack of funding, operating challenges, and "a lack of focus" all potentially contributed to the organization's impending closure.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clarence Herbert Clifton Iii, DPT 800 Crescent Centre Dr Ste 300, Franklin, TN 37067-7285 Ph: (615) 373-1350 | Clarence Herbert Clifton Iii, DPT 4957 Swinyar Dr Ste 103, Ooltewah, TN 37363-2205 Ph: (423) 664-0800 |
News Archive
Patients and physicians "need to know not just whether a new drug outperforms a placebo, but whether it's a real advance on what's already on the market," Richard Friedman, a professor of psychiatry at Weill Cornell Medical College, writes in a New York Times opinion piece.
ScinoPharm and Foresee Pharmaceuticals, Inc. jointly announced today that an investment agreement to form a joint venture has been signed. This venture looks to develop a series of peptide injectable drugs with the first being a new oncological Leuprolide injectable drug product, where Leuprolide will be formulated in a proprietary controlled-release drug delivery system originally developed by Foresee and transferred to the joint venture.
The Obama "administration's bold drive to improve the U.S.'s notoriously bureaucratic and dysfunctional foreign aid programme is setting out with highly uncertain chances of success," the Financial Times writes. "Officials acknowledge inadequacies in the traditional U.S. approach. The U.S. programme involves overlapping bureaucracies ... [and] frequently 'ties' U.S. aid to the purchase of American food and other goods and consultancy services," according to the article.
Arjen Dondorp, deputy director of the Mahidol Oxford Tropical Research Unit at Mahidol University in Bangkok, Thailand, and colleagues discuss the need to combat antimalarial drug resistance in this New England Journal of Medicine opinion piece, writing, "Researchers, funders, and policy leaders must recognize the urgency of the problem, take action to address simultaneously several important knowledge gaps, and focus immediately on eliminating the threat of artemisinin resistance."
Devex examines the April 20 announcement by the Global Health Council (GHC) that it will cease operations in the year of its 40th anniversary, discussing possible reasons why the organization is closing and what lies ahead for its members. According to Devex, a lack of funding, operating challenges, and "a lack of focus" all potentially contributed to the organization's impending closure.
› Verified 1 days ago
Logan Sims, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4957 Swinyar Dr Ste 103, Ooltewah, TN 37363 Phone: 423-664-0800 Fax: 423-664-0801 | |
Tawnya Ezra, Physical Therapist Medicare: Medicare Enrolled Practice Location: 5948 Howe Ln, Ooltewah, TN 37363 Phone: 423-238-9444 | |
Benchmark Physical Therapy Of Va, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 8823 Production Ln, Ooltewah, TN 37363 Phone: 423-238-7217 Fax: 423-238-3473 | |
Kristen Vogelbein, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 9408 Apison Pike Ste 150, Ooltewah, TN 37363 Phone: 423-396-3004 Fax: 423-396-3005 | |
Mrs. Twyla Cecilia Aasheim, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6711 Mountain View Rd, Suite 115, Ooltewah, TN 37363 Phone: 423-238-1127 Fax: 423-238-1277 | |
Allen Tyler Nance, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 8823 Production Ln, Ooltewah, TN 37363 Phone: 423-238-7217 Fax: 423-238-3473 | |
Mrs. Melissa Hardison Pettway, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3065 Roundabout Ln, Ooltewah, TN 37363 Phone: 423-314-8504 |